On Monday Dexcom Inc (NASDAQ: DXCM) opened higher 3.80% from the last session, before settling in for the closing price of $58.22. Price fluctuations for DXCM have ranged from $56.44 to $93.25 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 39.06% over the last five years. Company’s average yearly earnings per share was noted 25.87% at the time writing. With a float of $384.61 million, this company’s outstanding shares have now reached $390.00 million.
Dexcom Inc (DXCM) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Dexcom Inc is 1.39%, while institutional ownership is 94.14%. The most recent insider transaction that took place on Sep 05 ’25, was worth 53,934. In this transaction Director of this company sold 667 shares at a rate of $80.86, taking the stock ownership to the 22,667 shares. Before that another transaction happened on Sep 04 ’25, when Company’s EVP, Chief HR Officer sold 1,466 for $80.00, making the entire transaction worth $117,280. This insider now owns 105,223 shares in total.
Dexcom Inc (DXCM) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted 0.45 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at 0.5) by -0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.48 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 25.87% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 22.40% during the next five years compared to 39.06% growth over the previous five years of trading.
Dexcom Inc (NASDAQ: DXCM) Trading Performance Indicators
Check out the current performance indicators for Dexcom Inc (DXCM). In the past quarter, the stock posted a quick ratio of 1.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.22. Likewise, its price to free cash flow for the trailing twelve months is 22.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.80, a number that is poised to hit 0.65 in the next quarter and is forecasted to reach 2.51 in one year’s time.
Technical Analysis of Dexcom Inc (DXCM)
Analysing the last 5-days average volume posted by the [Dexcom Inc, DXCM], we can find that recorded value of 12.96 million was better than the volume posted last year of 4.41 million. As of the previous 9 days, the stock’s Stochastic %D was 22.76%.
During the past 100 days, Dexcom Inc’s (DXCM) raw stochastic average was set at 11.88%, which indicates a significant decrease from 25.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.03 in the past 14 days, which was lower than the 2.35 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $70.64, while its 200-day Moving Average is $78.14. Now, the first resistance to watch is $61.55. This is followed by the second major resistance level at $62.68. The third major resistance level sits at $64.20. If the price goes on to break the first support level at $58.90, it is likely to go to the next support level at $57.38. Now, if the price goes above the second support level, the third support stands at $56.25.
Dexcom Inc (NASDAQ: DXCM) Key Stats
There are currently 392,155K shares outstanding in the company with a market cap of 23.57 billion. Presently, the company’s annual sales total 4,033 M according to its annual income of 576,200 K. Last quarter, the company’s sales amounted to 1,157 M and its income totaled 179,800 K.
